The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicitySheila Miknyoczki, Bruce Ruggeri, Jean Husten et al.|Molecular Cancer Therapeutics|2007Cited by 112
Synthesis and structure–activity relationships of novel poly(ADP-ribose) polymerase-1 inhibitorsMing Tao, Robert L. Hudkins, Jean Husten et al.|Bioorganic & Medicinal Chemistry Letters|2005Cited by 48
Mixed-Lineage Kinase 1 and Mixed-Lineage Kinase 3 Subtype-Selective Dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: Optimization, Mixed-Lineage Kinase 1 Crystallography, and Oral in Vivo Activity in 1-Methyl-4-phenyltetrahydropyridine ModelsRobert L. Hudkins, John P. Mallamo, John T. Durkin et al.|Journal of Medicinal Chemistry|2008Cited by 43